Congressional Briefing | Friends of Cancer Research

You are here

Congressional Briefing

Safeguarding the Public Health: Enhancing Information About Prescription Drugs

To access a recap of this past event, please Click HERE.

Friends of Cancer Research Congressional Briefing

Safeguarding the Public Health: Enhancing Information About Prescription Drugs


Hart Senate Office Building

​Room 216

The Cancer Moonshot Initiative: Current and Future Cancer Research Objectives

Please join the

National Coalition for Cancer Research and the

American Association for Cancer Research

for our upcoming “Cancer 101” Congressional Briefing Series event:

 

The Cancer Moonshot Initiative:

Current and Future Cancer Research Objectives

 

Senate HELP Committee Hearing – “Laboratory Testing in the Era of Precision Medicine”

On September 20th, 2016, the Senate Health, Education, Labor and Pensions Committee convened a hearing to discuss laboratory testing the in the era of precision medicine. The hearing took place amid an ongoing debate over the proper regulatory framework for laboratory-developed tests (LDTs). LDTs are in vitro diagnostic tests (IVDs) that are made and performed within a single laboratory. They differ from IVDs that are manufactured and sold as diagnostic kits, which are performed at many labs that did not originate the test.

National Coalition for Cancer Research & One Voice Against Cancer: Briefing on the National Cancer Moonshot

          

Please join the National Coalition for Cancer Research &
 One Voice Against Cancer for a
Lunch briefing and Panel Discussion regarding the
National Cancer Moonshot Blue Ribbon Panel Report


Special Guest Speaker:

Friends of Cancer Research Senate Briefing: The Future of Precision Medicine & Patient Care

Senate Briefing

The Future of Precision Medicine & Patient Care:

Current Landscape in Genomic Testing

Thursday, October 13th, 2016 - 12:00pm-1:00pm

National Coalition for Cancer Research Briefing - The Cancer “Moonshot” Initiative: New Frontiers in Cancer Exploration

 

Please join the National Coalition for Cancer Research for their upcoming “Cancer 101” Congressional Briefing Series event:

 

The Cancer “Moonshot” Initiative:

New Frontiers in Cancer Exploration

 

Monday, April 25, 2016

12:00 – 1:30 pm

485 Russell Senate Office Building

Friends of Cancer Research Senate Briefing: Breakthrough Therapy Designation

Breakthrough Therapy Designation: Successes, Lessons Learned and Future Strategies

Tuesday, April 12, 2016 - 12:30pm-2:00pm

Capitol Visitor's Center, Room SVC 212-10
Washington, DC 20515

A Friends of Cancer Research Senate Briefing on the FDA's breakthrough therapy designation

Limited space is available.

Register Now!

Centers of Excellence at the FDA: A Disease-Oriented Approach to Medical Product Development

Centers of Excellence at the FDA:  A Disease-Oriented Approach to Medical Product Development

A Friends of Cancer Research (Friends) Senate Briefing on Opportunities for Cross-Center Coordination at the FDA to Reflect Current Patient Care

February 24, 2016 – 11:00am-12:00pm

US Capitol Visitors Center, SVC201-00 – Washington, DC

Event Summary:

Science and Progress at the FDA: A Friends of Cancer Research Congressional Briefing on the Progress of the FDA's Breakthrough Therapies Program

On May 6th,  Friends of Cancer Research (Friends) hosted a congressional briefing entitled, "Science and Progress at the FDA: A Friends of Cancer Research Congressional Briefing on the Progress of the FDA's Breakthrough Therapy Program." The event was sponsored by Senators Michael Bennet (D-CO), Orrin Hatch (R-UT), and Richard Burr (R-NC), who together introduced the initial legislative proposal for this program, the "Advancing Breakthrough Therapies for Patients Act," in March of 2012. In just two years, 178 requests for Breakthrough Designation have been submitted, 44 designations have b

Pages